Sung H. Lee
EVP & CFOMr. Sung H. Lee is Independent Director of Tango Therapeutics, Inc. from January 5, 2026 and serves as its Lead Independent Director since May 13, 2026. Mr. Lee serves as Executive Vice President and Chief Financial Officer of Cytokinetics, Incorporated since May 08, 2024 and also served as its Principal Accounting Officer since December 31, 2024. He has been Chief Financial Officer and Member of Management Board at MorphoSys AG since February 2, 2021. He served as Executive Vice President and Chief Financial Officer at Vir Biotechnology Inc. since March 27, 2023 until May 03, 2024. He had served as a Secretary of Vir Biotechnology, Inc. He was Executive Vice President and Chief Financial Officer of Sangamo Therapeutics, Inc. since October 31, 2019 until February 1, 2021. Mr. Lee was Vice President of Investor Relations at Gilead Sciences, Inc. since June, 2016. Mr. Lee joined Sangamo from Gilead Sciences, where he spent many years and served as Senior Vice President, leading the financial planning & analysis (FP&A) and investor relations functions. In this dual capacity, he managed the global planning and budgeting process, drove process improvement and managed all aspects of communications to the investor community. Prior to this role, Mr. Lee held roles of increasing responsibility at Gilead, including Head of Europe Finance and Head of R&D FP&A. Mr. Lee received a B.A. in Economics from University of California, Irvine and Master of Business Taxation from University of Southern California.
Positions
- Company NameCytokinetics, IncorporatedStock CodeCYTKPositionEVP & CFOColleagues
- RIRobert I. BlumCEO, President & Director
- JTJohn Tannahill HendersonIndependent Chairman
- JJJeffrey J. HessekielExecutive VP, Chief Legal & Administrative Officer
- FIFady Ibraham MalikExecutive Vice President of Research & Development
- AMAndrew M. CallosExecutive VP & Chief Commercial Officer
- JHJames H. SabryCo-Founder & Chairman of Scientific Advisory Board
- JAJames A. SpudichCo-Founder & Member of Scientific Advisory Board
- BLB. Lynne ParshallIndependent Director
